Journal article icon

Journal article

Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy

Abstract:
AbstractDuchenne muscular dystrophy (DMD) is an X-linked progressive muscle-wasting disorder that is caused by a lack of functional dystrophin, a cytoplasmic protein necessary for the structural integrity of muscle. As variants in the dystrophin gene lead to a disruption of the reading frame, pharmacological treatments have only limited efficacy; there is currently no effective therapy and consequently, a significant unmet clinical need for DMD. Recently, novel genetic approaches have shown real promise in treating DMD, with advancements in the efficacy and tropism of exon skipping and surrogate gene therapy. CRISPR-Cas9 has the potential to be a ‘one-hit’ curative treatment in the coming decade. The current limitations of gene editing, such as off-target effects and immunogenicity, are in fact partly constraints of the delivery method itself, and thus research focus has shifted to improving the viral vector. In order to halt the loss of ambulation, early diagnosis and treatment will be pivotal. In an era where genetic sequencing is increasingly utilised in the clinic, genetic therapies will play a progressively central role in DMD therapy. This review delineates the relative merits of cutting-edge genetic approaches, as well as the challenges that still need to be overcome before they become clinically viable.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41431-021-00811-2

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3906-5317
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8807-8520


More from this funder
Funder identifier:
10.13039/501100000265
Grant:
150AV003/CA2


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
European Journal of Human Genetics More from this journal
Volume:
29
Issue:
9
Pages:
1369-1376
Publication date:
2021-02-09
DOI:
EISSN:
1476-5438
ISSN:
1018-4813


Language:
English
Keywords:
Pubs id:
1161600
Local pid:
pubs:1161600
Source identifiers:
W3127238805
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP